287
Participants
Start Date
March 5, 2018
Primary Completion Date
August 12, 2019
Study Completion Date
August 21, 2019
Acarbose
Uptitrated in the treatment phase from 50 mg per day for 1 week, followed by 100 mg per day for another week, and 150 mg per day for the rest 14 weeks, oral, with the first mouthful of main meal
Metformin
500 mg 3 times daily, oral, with the first mouthful of main meal
Placebo
Acarbose matching placebo, oral
Emergency General Hospital, Beijing
Peking Union Medical College Hospital CAMS, Beijing
Beijing Pinggu Hospital, Beijing
Jilin Province People's Hospital, Changchun
Shanghai Tenth People's Hospital, Shanghai
Jiangsu Province Hospital, Nanjing
1st Peopl's Hosp of Changzhou 3rd Affil Hosp of Soochow Univ, Changzhou
Huai'an First People's Hospital, Nanjing Medical University, Huai'an
Northern Jiangsu People's Hospital, Yangzhou
Anhui Provincial Hospital, Hefei
The First Affiliated Hospital of Anhui Medical University, Hefei
Shandong Provincial Hospital, Jinan
Affiliated Hospital of Jining Medical University, Jining
Tianjin Union Medicine Centre (People's Hospital of Tianjin), Tianjin
Jiangxi PingXiang people's Hospital, Pingxiang
Changsha Central Hospital, Changsha
Chenzhou No. 1 People's Hospital, Chenzhou
Tongji Hosp. of Tongji Med Coll, Huazhong Uni of Sci & Tech., Wuhan
Taihe Hospital, Shiyan
The first affiliated hospital of Zhengzhou University, Zhengzhou
1st Affiliated Hospital of Henan Science and Technology Univ, Luoyang
The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou
Sun Yat-Sen Memorial Hosp. Sun Yat-Sen Univ., Guangzhou
The 3rd Affiliated Hospital of Guangzhou Medical University, Guangzhou
The Second Affliated Hospital of Hainan Medical University, Haikou
Hainan Third People's Hospital (Province Nongken Sanya Hopt), Sanya
West China Hospital, Sichuan University, Chengdu
1st Affiliated Hospital of Xi'an Jiaotong Medical University, Xi'an
People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi
Lead Sponsor
Bayer
INDUSTRY